GlassScriptPhysician profile
Michael T Ellerbusch
NPI 1437107984
$776.85
in general payments reported to CMS, 2019-2025
9 companies · $90.42 in 2025
The $90.42 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $163 · 2021: $154 · 2022: $58.88 · 2023: $34.12 · 2024: $57.03 · 2025: $90.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $456.27 | 2019-2021 | |
| Depuy Synthes Sales INC. | $92.86 | 2019-2025 | Truespan Orthocord, Healix Knotless Peek, Dynacord |
| Pacira Pharmaceuticals Incorporated | $78.24 | 2022-2024 | Exparel, Zilretta |
| Boston Scientific Corporation | $43.08 | 2023-2025 | Spectra Wavewriter |
| Amgen INC. | $31.73 | 2025 | Krystexxa |
| Heraeus Medical, LLC. | $26.91 | 2020 | |
| Horizon Therapeutics Plc | $18.34 | 2022 | |
| Pfizer INC. | $16.04 | 2020 | |
| Radius Health, INC. | $13.38 | 2023 | Tymlos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ellerbusch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.